THE PRESENT INVENTION RELATES TO A ROLLER COMPACTED SOLID ORAL DOSAGE FORM COMPRISING A THERAPEUTICALLY EFFECTIVE AMOUNT OF ALISKIREN, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, WHEREIN THE ACTIVE INGREDIENT IS PRESENT IN AN AMOUNT OF MORE THAN 38% BY WEIGHT BASED ON THE TOTAL WEIGHT OF THE ORAL DOSAGE FORM, AS WELL AS A PROCESS OF PREPARING SAID SOLID ORAL DOSAGE FORM.
